Penn Medicine is mentioned for its involvement, in collaboration with the Children’s Hospital of Philadelphia, in receiving the approval of the world’s first genetically engineered immune therapy for pediatric leukemia.

September 12, 2017 ・ From Philadelphia Inquirer